Cervical adenosquamous carcinoma

MONDO:0006134

An uncommon carcinoma arising from the cervix. It is composed of malignant glandular epithelial cells and malignant squamous epithelial cells.

Also known as: adenosquamous cell carcinoma of cervix, adenosquamous cell carcinoma of cervix uteri, adenosquamous cell carcinoma of the cervix, adenosquamous cell carcinoma of the cervix uteri, adenosquamous cell carcinoma of the uterine cervix, adenosquamous cell carcinoma of uterine cervix, cervical adenosquamous cancer, cervical adenosquamous carcinoma

2857 clinical trials for this condition and its sub-types, 16 tagged with Cervical adenosquamous carcinoma itself.

Follow this condition to get notified about new trials

Where it sits in the disease tree

Browse by category →

Part of

↑ Adenosquamous carcinoma (45) ↑ Cervical squamous cell carcinoma (40) ↑ Cervical adenocarcinoma (34)

Sub-types of Cervical adenosquamous carcinoma

Cervical adenosquamous carcinoma, glassy cell variant 0 trials

Including sub-types (2857) Tagged with Cervical adenosquamous carcinoma (16)

Trials to join now! 7 Not yet recruiting 1 Not yet finished but already full! 6 Completed 2

New drug cocktail aims to stop cervical cancer return

Disease control Not yet recruiting

This phase II trial tests whether adding pembrolizumab and lenvatinib to standard chemoradiation and brachytherapy can improve outcomes for adults with high-risk locally advanced cervical cancer. About 87 participants will receive the drug combination and be followed for two year…

Phase 2 • Sponsor: Prof. Dr. Remi A. Nout • Aim: Disease control

Last updated Jun 27, 2026 09:00 UTC

Cervical adenosquamous carcinoma

Where it sits in the disease tree

New drug cocktail aims to stop cervical cancer return